Open original FDA record ↗Recall record
- FDA identifier
- Z-2172-2008
- Company in FDA record
- Medtronic Neuromodulation
- FDA classification date
- Aug 27, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The SC catheters cannot completely engage with the Model 700-04M portal connector. The result of this condition is a possible leakage or disconnect of the SC catheter from the portal during the continuous therapy trial period.
Source facts
- Action
- Medtronic informed all Belgium implanting and managing physicians of the SynchroMed II infusion system. Each customer was mailed a Dear Healthcare Professional letter (Medtronic Urgent: Field Safety Notice) on 4/3/08 providing important safety information and patient management recommendations regarding the device incompatibility. The firm recommends that healthcare professionals do not use SC catheters if a connection with an implantable access port is required. Also, if a continuous infusion trial is required with use of an implantable access port, they should use a model 8711 intrathecal catheter. The firm states that for patients who are currently undergoing a continuous trial with an implantable port, replacing the catheter connector before connecting to the SynchroMedd II using the Medtronic model 8578 revision kit is recommended. Medtronic also recommends discussing the risks of connection failure with patients. Local field reps will personally follow-up with affected customers to confirm and document notification.
- Initiated
- 2008-04-14
- Root cause
- Device Design
- Terminated
- 2008-09-10
- Distribution
- International Distribution --- country of Belgium.
- Recall number
- Z-2172-2008
- Recall status
- Terminated
- CDRH record ID
- 71792
- FDA classified
- 2008-08-27
- Recall event number
- 48616